ChatGPT has recently become a global hit due to its advanced conversational capability. It has reached 100 million monthly active users in just two months after it was first released in late November 2022.

As a smart chatbot capable of answering questions in most areas, we are trying to find out how much does ChatGPT know about DNBSEQ-T20×2 and DNBSEQ-G99, MGI's newly launched gene sequencers at AGBT 2023. Let's see what ChatGPT has to say.

MGI: DNBSEQ-T20×2 can produce up to 50,000 WGS per year. How do you interpret that number?

ChatGPT: It means that DNBSEQ-T20×2 can generate this amount of genomic data in one year. This is a substantial amount of sequencing data and demonstrates the high-throughput capability of the DNBSEQ-T20×2 sequencer. The number "50,000 WGS per year" is a also useful benchmark that provides an indication of the sequencing capacity of the DNBSEQ-T20×2 sequencer.

MGI: DNBSEQ-T20×2 brings the cost of whole genome sequencing down to $100. What does that number mean?

ChatGPT: It means DNBSEQ-T20×2 brings a significant reduction in the cost of whole genome sequencing, as it was only a few years ago that the cost of sequencing a human genome was several thousand dollars. This reduction in cost makes whole genome sequencing more accessible to a wider range of individuals and organizations, including those in developing countries. Meanwhile, the $100 figure is a useful benchmark that provides an indication of the declining cost of whole genome sequencing and the impact of advances in sequencing technology.

MGI: What are the biggest highlights and innovations of DNBSEQ-G99?

ChatGPT: DNBSEQ-G99 is a gene sequencer developed by MGl, which is a cutting-edge sequencing platform that offers several key highlights and innovations including:

· High accuracy: DNBSEQ-G99 has been designed to deliver high accuracy and precision in sequencing, ensuring that the data generated is of high quality and reliable.

· Cost-effectiveness: DNBSEQ-G99 has been designed to be cost-effective, making it an attractive option for smaller-scale applications in research and clinical settings.

· Scalability: DNBSEQ-G99 can be easily scaled to meet the needs of different types of projects and applications, making it a flexible and versatile sequencer.

Overall, DNBSEQ-G99 is a cutting-edge sequencing platform that offers a range of benefits and innovations, making it a valuable tool for researchers, clinicians, and professionals in the genomics field.

We also try to get ChatGPT to talk about breakthroughs and the future of the gene sequencing industry.

MGI: What does it mean the cost of sequencing a human genome is dropping faster than Moore's Law?

ChatGPT: It refers to the rapid decrease in the cost of determining the complete sequence of a human genome, Moore's Law is a famous observation in the computer industry that states that the number of transistors on a computer chip will double approximately every two years, leading to exponential growth in computing power and a decrease in the cost of computer hardware.

The rapid decrease in the cost of sequencing a human genome has major implications for the future of medicine, as it makes genomic sequencing increasingly accessible and affordable, allowing for the development of new treatments and therapies based on an individual's unique genetic makeup.

MGI: What is genomic sequencing and why does it matter for the future of health?

ChatGPT: Genomic sequencing is the process of determining the complete DNA sequence of an organism's genome. This includes identifying the specific order of the four building blocks of DNA (adenine, guanine, cytosine, and thymine) that make up the genome. Genomic sequencing has the potential to revolutionize the future of health in several ways:

· Precision medicine: By understanding an individual's unique genetic makeup doctors can tailor treatments to that person's specific needs, leading to more effective and personalized care, this is particularly important for individuals with genetic predispositions to certain conditions, such as certain cancers.

· Early disease detection: By analyzing a person's genome, it may be possible to detect signs of disease long before symptoms appear. This allows for early intervention and potentially better outcomes.

· lmproved understanding of disease: Genomic sequencing can provide valuable information about the genetic basis of diseases, which can lead to the development of new treatments and therapies.

· Development of new drugs: Genomic information can help identify specific targets for drug development, leading to the creation of new and more effective treatments for a variety of diseases.

· Reduction of health disparities: By understanding the genomic basis of disease, it may be possible to reduce health disparities and improve outcomes for underserved populations.

Overall, genomic sequencing has the potential to transform the way we approach health and medicine leading to better outcomes, improved patient care, and a more precise understanding of the genetic basis of disease.

MGI: What are the clinical applications of gene sequencing technology?

ChatGPT: There are many clinical applications of gene sequencing technology, including:

· Diagnosis of genetic disorders: Gene sequencing can be used to diagnose a variety of genetic conditions, including rare inherited diseases, birth defects, and chromosomal abnormalities.

· Cancer diagnosis and treatment: Gene sequencing can be used to identify specific genetic mutations that drive the development of cancer, allowing for more personalized and effective treatments.

· Precision medicine: Gene sequencing can be used to tailor treatments to an individual's specific genetic makeup, leading to more effective and personalized care. This is particularly important for individuals with genetic predispositions to certain conditions, such as certain cancers.

· Dentification of genetic risks: Gene sequencing can be used to identify an individual's genetic risks for a variety of conditions, such as heart disease, stroke, and certain cancers. This information can help individuals and their healthcare providers take steps to reduce their risk of developing these conditions5Carrier testing: Gene sequencing can be used to identify carriers of genetic conditions, allowing individuals and families to make informed decisions about their health and family planning.

· Newborn screening: Gene sequencing can be used to screen newborns for a variety of genetic conditions, allowing for early detection and treatment of these conditions.

· Forensics: Gene sequencing can be used in forensic investigations to identify individuals from their DNA, as well as to track the transmission of genetic diseases through families.

These are just a few examples of the many clinical applications of gene sequencing technology. As the field continues to evolve and our understanding of genetics expands, it is likely that there will be many more applications for gene sequencing in the future.

MGI: What are the future applications of gene sequencing technology?

ChatGPT: The future applications of gene sequencing technology are vast and varied, and will likely continue to expand as the field continues to evolve. Some of the most exciting future applications include:

· Precision medicine: Gene sequencing technology will continue to play a key role in the development of precision medicine, which aims to tailor treatments to the unique genetic makeup of each individual patient.

· Personalized nutrition: Gene sequencing may be used to develop personalized dietary recommendations based on an individual's genetic makeup and health status, allowing for more effective and targeted health and wellness interventions.

· New treatments for genetic disorders: As our understanding of genetics continues to expand, gene sequencing may lead to the development of new treatments for a wide range of genetic disorders, including rare and previously untreatable conditions.

· Improved cancer diagnosis and treatment: Gene sequencing technology will likely play a crucial role in the ongoing efforts to improve our understanding of the biological processes underlying the development and progression of cancer, and to develop new and better treatments for this disease.

· Environmental and food safety: Gene sequencing may be used to track the spread of foodborne illnesses and to monitor the safety of the food supply, helping to prevent outbreaks and protect public health.

· Agricultural biotechnology: Gene sequencing may be used to develop new and improved crops, with higher yields, improved resistance to pests and disease, and greater tolerance for environmental stressors.

· Improved public health: Gene sequencing may be used to track the spread of infectious diseases and to identify the source of outbreaks, allowing for more effective and targeted interventions to protect public health.

These are just a few examples of the many exciting future applications of gene sequencing technology. As the field continues to evolve, it is likely that new innovative uses for gene sequencing will emerge, helping to transform our understanding of genetics and improve human health and well-being.

The ultra-high throughput sequencer DNBSEQ-T20×2 further completed MGI's product portfolio from low- to ultra-throughput. Featured ultra-high throughput, ultra-low cost and high intelligence, DNBSEQ-T20×2 breaks the boundaries to read the sequence of hole Human Genome for sub $100, making human genome sequencing more accessible. 

Lastly, let's take a look at how ChatGPT thinks of MGI's sequencing platform.

MGI: Will high or ultra-high throughput gene sequencers become a future trend?

ChatGTP: Yes, high-throughput and ultra-high-throughput gene sequencers are likely to become a future trend in the field of genomics. The development of new and improved sequencing technologies has dramatically increased the speed, accuracy and cost-effectiveness of genomic sequencing, making it possible to sequence the genomes of large numbers of individuals and samples in a relatively short period of time.

As the cost of sequencing continues to decline and the demand for genomic information continues to increase, it is likely that high-throughput and ultra-high throughput sequencing technologies will become more widely adopted, both in research and in clinical. These technologies will likely play a crucial role in the ongoing efforts to improve our understanding of genetics and human biology and to develop new and better treatments for a wide range of diseases.

In the future, high-throughput and ultra-high-throughput sequencers may also become an increasingly important tool in the fields of personalized medicine and precision health, allowing for the rapid and accurate assessment of individuals' genomic information and the development of targeted, individualized treatments.

MGI: What are the advantages of the MGl's gene sequencer?

ChatGTP: MGl is a leading genomics company that develops and produces a range of gene sequencer products. The advantages of these gene sequencers depend on the specific product, but some of the general advantages of MGl's gene sequencer technology include:

· High throughput: MGl's gene sequencers are designed to sequence large numbers of samples in a relatively short period of time, making them well-suited for large-scale genomic studies.

· High accuracy: MGl's gene sequencers are known for their high accuracy, which is crucial for a wide range of applications, including disease diagnosis, drug development and genetic research.

· Affordable cost: MGl is committed to making genomics accessible and affordable for researchers and healthcare providers around the world. This is reflected in the cost-effective design of its gene sequencer products.

· User-friendly software: MGI's gene sequencer products come with user-friendly software that makes it easy for researchers and healthcare providers to obtain and analyze genomic data.

· Robust data management: MGl's gene sequencer products are designed to generate large amounts of data, and the company offers robust data management solutions to help users manage, store, and analyze this data.

These are just a few examples of the many advantages of MGl's gene sequence technology. As the field of genomics continues to evolve, it is likely that MGl will continue to develop new and improved gene sequencer products, with even more advanced capabilities and features.

PS: we really didn't put ad on ChatGPT :)

*Unless otherwise informed, StandardMPS and CoolMPS sequencing reagents, and sequencers for use with such reagents, are not available in Germany, Spain, UK, Sweden, Belgium, Italy, Finland, Czech Republic, Switzerland, Portugal, Austria, and Romania. Unless otherwise informed, StandardMPS sequencing reagents, and sequencers for use with such reagents are not available in Hong Kong.